More on ATYR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+61.5% Growth)
- Ratings (3.0 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

aTyr Pharma (NQ:ATYR)
Delayed: 0.17 -0.01 (5.56%)
Prev. Close $0.18  
Open$0.19 
52 Wk High$ 
52 Wk Low$ 
Day High$0.19 
Day Low$0.17 
P/E N/A  
EPS$ 
Volume1,818,939 

Friends, Peers and Foes (?): ASBP, COCH, CTSO, IMNN, JAGX (more...)

Oct 16, 2026 04:03 PM Form 8-K aTYR PHARMA INC For: Oct 16
Oct 13, 2026 08:04 AM aTyr Pharma publishes anti-fibrotic findings for ATYR0101
Oct 13, 2026 08:01 AM aTyr Pharma Announces Publication Demonstrating Anti-Fibrotic Effects of ATYR0101 in the Journal of Biological Chemistry
Oct 7, 2026 07:19 AM Form SCHEDULE 13G/A aTYR PHARMA INC Filed by: FEDERATED HERMES, INC.
Oct 1, 2026 04:04 PM Form 4 aTYR PHARMA INC For: Oct 01 Filed by: Yaras Brandon
Oct 1, 2026 04:02 PM Form 3 aTYR PHARMA INC For: Oct 01 Filed by: Yaras Brandon
Sep 24, 2026 07:48 AM Form 8-K aTYR PHARMA INC For: Sep 24
Sep 24, 2026 06:00 AM aTyr Pharma reaches FDA alignment on Phase 3 efzofitimod study
Sep 24, 2026 06:00 AM aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
Sep 11, 2026 04:06 PM Form DEF 14A aTYR PHARMA INC For: Oct 16
View All Articles

Entities mentioned with ATYR

View All Entities